Novo Nordisk said on Friday the U.S. Food and Drug Administration had granted accelerated approval for its weight-loss drug ...

Novo Nordisk’s obesity drug Wegovy was cleared by U.S. regulators to treat an increasingly common liver disease, MASH.

Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved an additional indication for Wegovy® ...

Yankees can mash, but playoffs will expose run prevention weakness again originally appeared on Athlon Sports. The Yankees ...

Amateur fossil hunter Ross Dullard, who found the partial skull, says he will celebrate with a whale-themed party, marking ...

HistoIndex’s AI-based FibroSIGHT Plus’s launch coincides with the MASH space’s pharma market potential swelling across the ...

I am reversing my rating on Akero Therapeutics stock from Buy to Sell due to valuation concerns and a long-ish wait for ...

These buffalo chickpea sandwiches are made with chickpeas, hot sauce, dill pickles, green onions, celery, and ranch dressing ...

Nikki Glaser Says Hearing Herself in Taylor Swift's 'Miss Americana' Was 'One of the Worst Feelings Ever' ...

The Food and Drug Administration (FDA) has further expanded the U.S. indications of Novo Nordisk’s (NVO) popular weight loss ...

MASLD has become the most common chronic liver disease worldwide. The authors review the features of the disease as well as ...

Fowling, the mash-up of football and bowling, is coming to Minneapolis at new venue originally appeared on Bring Me The News.